Indegene Limited’s Board of Directors convened on October 29, 2026, to approve the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The board also approved the allotment of equity shares under the RSU Scheme 2020 and ESOP Scheme 2020. Key personnel resignations were noted and accepted, including that of Mr. Mark Francis Dzialga and Ms. Srishti Ramesh Kaushik.
Indegene Board Meeting Outcomes
The Board of Directors of Indegene Limited held a meeting on Thursday, October 29, 2026, where several key decisions were made. Foremost among these was the approval of the unaudited standalone and consolidated financial results, along with the limited review report from the auditors, for the second quarter and half-year ended September 30, 2026.
Share Allotment and Personnel Changes
Further, the Board approved the allotment of shares under the RSU Scheme 2020 and ESOP Scheme 2020. Detailed particulars regarding these allotments are provided in Annexure – B. The meeting also noted and accepted the resignation of Mr. Mark Francis Dzialga from the position of Non-Executive – Non-Independent Director, effective from the close of business hours on October 29, 2026. The Board expressed its appreciation for his contributions.
Subsequently, the Nomination and Remuneration Committee and Investment Committee were re-constituted following Mr. Dzialga’s cessation from these committees. The composition of the reconstituted committees is detailed in Annexure – D. Additionally, the resignation of Ms. Srishti Ramesh Kaushik from the position of Company Secretary, Compliance Officer, and Key Managerial Personnel was accepted. She will be relieved of her duties effective from the close of business hours on December 02, 2026. Details are in Annexure – F.
Policy Amendments and Trading Window
The Board also approved an amendment to the Prevention of Sexual Harassment Policy of the Company. In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Company’s securities by Designated Persons will reopen on Monday, November 02, 2026. The Board meeting commenced at 06:30 PM (IST) and concluded at 07:16 PM (IST).
The financial results and related information have been made available on the Company’s website: https://www.indegene.com/.
Source: BSE
